Assembly Biosciences Inc Share Price

NASDAQ: ASMB

Small Cap

$21.84

-0.75

(-3.34%)

as on September 13, 2025 at 1:29 am IST

$₹

Assembly Biosciences Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$21.66
Day's Price Range
$22.84
$21.84
0.82%
Downside
4.58%
Upside
52 Week's Low
52 Week's High
$7.75
52-Week Price Range
$27.17
$21.84
64.51%
Downside
24.42%
Upside

Assembly Biosciences Inc share price movements today

Previous Close: $22.59
Open: $22.64
Volume: 227.8K
Day's Low - High: $21.66 - $22.84
52 Week Low - High: $7.75 - $27.17

Assembly Biosciences Inc Historical Returns

1 Month Return: -11.72 %
3 Month Return: + 29.67 %
1 Year Return: + 20.92 %
3 Year Return: -15.31 %
5 Year Return: -89.43 %

Assembly Biosciences Inc Stock Fundamentals & Key Indicators

Check Assembly Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$351.5M

EPS (TTM)

-2.885

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-43.4M

Revenue (TTM)

33.2M

Profit Margin

-117.20%

Return On Equity TTM

2180500.00%

Assembly Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Assembly Biosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Assembly Biosciences Inc	BUY	$351.5M	-89.43%	NA	-117.20%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Stock Returns calculator for Assembly Biosciences Inc Stock including INR - Dollar returns

The Assembly Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Assembly Biosciences Inc investment value today

Current value as on today

₹1,25,979

Returns

₹25,979

(+25.98%)

Returns from Assembly Biosciences Inc Stock

₹20,863 (+20.86%)

Dollar Returns*

₹5,115 (+5.12%)

Analyst Recommendation on Assembly Biosciences Inc Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Assembly Biosciences Inc. Average target price of $38.25

Assembly Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Assembly Biosciences Inc.

What analysts predicted

42.9%UPSIDE

Target Price

$38.25

Current Price

$21.84

Analyzed by

8 Analysts

Target

$38.25

Assembly Biosciences Inc target price $38.25, a slight upside of 42.9% compared to current price of $21.84. According to 8 analysts rating.

Assembly Biosciences Inc Stock's Interest Amongst Investors

Search interest for Assembly Biosciences Inc Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 14, 2025 to September 13, 2025

Change:-50% versus previous 30 day period

Assembly Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	7	5	8	6	7	9	9
Gross Profit	0	0	0	7	5	8	6	7	9	-
Operating Income	-19	-17	-15	-12	-10	-12	-10	-11	-9	-11
EBITDA	-19	-17	-14	-12	-10	-12	-10	-11	-9	-11
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-18	-16	-14	-10	-9	-10	-9	-10	-8	-10
Income Tax Expense	0	0	0	0	0	0	-	0	-	-
Net Income	-18	-16	-14	-10	-9	-11	-9	-10	-8	-10
Net Profit Margin	0.00%	0.00%	0.00%	-153.04%	-156.91%	-130.69%	-140.44%	-140.48%	-93.62%	-105.94%

Assembly Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	9	14	15	79	6	-	7	28
Gross Profit	0	0	-35	-57	15	79	5	0	-41	28
Operating Income	-29	-45	-52	-92	-102	-64	-132	-94	-64	-45
EBITDA	-29	-44	-52	-92	-102	-64	-91	-93	-64	-45
Interest Expense	-	-	-	-	4	2	82	0	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-28	-44	-51	-89	-98	-62	-132	-93	-61	-39
Income Tax Expense	-1	0	-9	1	0	-2	-2	-1	0	0
Net Income	-28	-44	-42	-90	-97	-59	-129	-92	-61	-40
Net Profit Margin	0.00%	0.00%	-474.66%	-613.02%	-611.63%	-75.25%	-2076.35%	0.00%	-854.78%	-140.87%

Assembly Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-16	-14	-10	-9	-11	-9	-10	-8	-10
Operating Cash Flow	-13	-13	73	-18	-17	-15	0	-23	-16
Investing Cash Flow	-8	18	-89	17	5	24	-6	6	16
Financing Cash Flow	0	-	9	-	12	-	16	1	0
Change in Cash	-21	5	-4	-1	0	9	9	-14	0

Assembly Biosciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-44	-42	-90	-97	-62	-129	-93	-61	-40
Operating Cash Flow	-34	1	-64	-84	-62	-93	-84	22	-51
Investing Cash Flow	36	-15	-135	-50	68	26	90	-69	40
Financing Cash Flow	0	67	159	139	7	53	0	13	29
Change in Cash	1	53	-40	5	12	-13	6	-32	18

Global Institutional Holdings in Assembly Biosciences Inc

Funds	Holdings
Vanguard Group Inc	2.82%
B Group, Inc	2.61%
Renaissance Technologies Corp	1.48%
BlackRock Inc	1.03%
Geode Capital Management, LLC	0.62%

See all

Insights on Assembly Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 141.1%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 55.1%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ASMB stock has moved down by -8.5%

About Assembly Biosciences Inc

assembly biosciences, inc. (nasdaq: asmb) is a public clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis b virus (hbv) infection and novel oral live biotherapeutics for disorders associated with the microbiome. assembly is developing two innovative platform programs: an hbv program advancing a new class of oral therapeutics for the treatment of hepatitis b virus (hbv) infection and a microbiome program developing novel oral live biotherapeutics designed to address diseases associated with the microbiome. assembly’s hbv program is advancing multiple drug candidates with the aim of increasing cure rates in patients with chronic hbv. the company's microbiome program consists of a fully integrated platform that includes a robust strain identification and selection process, methods for strain isolation and growth under current good manufacturing practices and a patent-pending delivery system, gemicel®, which allows for targeted ora

Organisation	Assembly Biosciences Inc
Headquarters	Two Tower Place, South San Francisco, CA, United States, 94080
Industry	Health Technology
CEO	Mr. Jason A. Okazaki J.D.
E-voting on shares	Click here to vote

Key Management of Assembly Biosciences Inc

Name	Title
Mr. Jason A. Okazaki J.D.	CEO, President & Director
Dr. Nicole S. White Ph.D.	Chief Manufacturing Officer
Dr. Anuj Gaggar M.D., Ph.D.	Chief Medical Officer
Mr. Thomas E. Rollins	Executive Officer
Amy Figueroa C.F.A.	Investor Relations Consultant
Dr. William E. Delaney IV, Ph.D.	Chief Scientific Officer
Ms. Jeanette M. Bjorkquist	Principal Financial Officer, Executive Director of Accounting & Treasury
Mr. Shannon Ryan	Senior Vice President of Investor Relations, Corporate Affairs & Alliance Management
Ms. Jennifer A. Troia MHROD, SHRM-SCP, SPHR	Chief Human Resources Officer

FAQs

What is Assembly Biosciences Inc share price today?

Assembly Biosciences Inc share price today is $21.84 as on September 13, 2025 at 1:29 am IST at the close of the market. Assembly Biosciences Inc share today touched a day high of $22.84 and a low of $21.66.

What is the 52 week high and 52 week low for Assembly Biosciences Inc share?

Assembly Biosciences Inc share touched a 52 week high of $27.17 on August 22, 2025 and a 52 week low of $7.75 on April 7, 2025. Assembly Biosciences Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $21.84,which is 19.63% down from its 52 week high and 181.81% up from its 52 week low.

What is Assembly Biosciences Inc's market capitalisation today?

Assembly Biosciences Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Assembly Biosciences Inc Stock (ASMB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Assembly Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Assembly Biosciences Inc Shares that will get you 0.0687 shares as per Assembly Biosciences Inc share price of $21.84 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Assembly Biosciences Inc Stock (ASMB) from India?

Indian investors can start investing in Assembly Biosciences Inc (ASMB) shares with as little as ₹88.25 or $1 (as of September 13, 2025 at 4:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.50 in Assembly Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on September 13, 2025 at 4:43 pm IST). Based on Assembly Biosciences Inc share’s latest price of $21.84 as on September 13, 2025 at 1:29 am IST, you will get 0.4579 shares of Assembly Biosciences Inc. Learn more about fractional shares .

What are the returns that Assembly Biosciences Inc has given to Indian investors in the last 5 years?

Assembly Biosciences Inc stock has given -89.43% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?